7 results match your criteria: "Cedarville University in Cedarville[Affiliation]"
Biologics for severe asthma.
Nursing
April 2024
Morgan E. Faulconer is a pharmacy student at Cedarville University in Cedarville, OH. Daniel J. Sheridan is a Medication Safety Pharmacist at OhioHealth Marion General Hospital in Marion, OH, and a member of the Nursing2024 Editorial Board.
Diluting I.V. push medications: Risky business.
Nursing
August 2021
Emily Wicker is a graduate of Cedarville University in Cedarville, Ohio. Daniel J. Sheridan is medication safety pharmacist at OhioHealth Marion General Hospital in Marion, Ohio, and a member of the Nursing2021 editorial board.
Responding to an opioid overdose in a healthcare facility visitor.
Nursing
December 2020
Michal Renihan is a PharmD graduate of Cedarville University in Cedarville, Ohio; Melissa Skocdopole is a PharmD graduate of Ohio Northern University in Ada, Ohio; and Dan Sheridan is a medication safety pharmacist at OhioHealth Marion General Hospital in Marion, Ohio, as well as a member of the Nursing2020 Editorial Board.
Pharmacogenomics: Overview of Applications and Relation to Infusion Therapy.
J Infus Nurs
March 2017
Manchester University College of Pharmacy, Fort Wayne, Indiana (Drs Kisor and Smith); Ferris State University, Big Rapids, Michigan (Dr Bright); and Cedarville University, Cedarville, Ohio (Dr Manion). David F. Kisor, PharmD, BS, is the chair of pharmaceutical sciences at Manchester University College of Pharmacy. His focus is on the fields of pharmacokinetics-related pharmacogenomics. He has more than 40 publications, including a textbook on pharmacogenetics, and he has served as the chair of the pharmacogenomics special interest group of the American Association of Colleges of Pharmacy. David R. Bright, PharmD, BS, is an associate professor of pharmacy practice at Ferris State University. His focus is on community and ambulatory care pharmacy practice. He has emphasized the incorporation of pharmacogenomics into medication therapy management and collaborative drug therapy management, where he works to evaluate implementation models in the community and in transition-of-care settings. Chelsea R. Manion, PharmD, practices in oncology, inpatient, and infusion-center settings, as well as among underserved populations. Her focus in oncology care is on symptom management, patient education, and interdisciplinary health care collaboration. She is an assistant professor of pharmacy practice at Cedarville University in Cedarville, Ohio. Thomas R. Smith, PharmD, is trained in psychiatry and neurology. He currently focuses his efforts in the inpatient psychiatry setting on therapeutics and patient education. He has included pharmacogenomic data in drug therapy management, focusing on clinical applications. Dr. Smith is an assistant professor of pharmacy practice at Manchester University College of Pharmacy, Fort Wayne, Indiana.
Pharmacogenomics (PGx) describes the relationship between an individual's genes and his or her response to drug therapy. Data are accumulating that indicate that PGx has application in the clinical setting for drugs across therapeutic categories, including drugs that are administered intravenously and are of greater familiarity to infusion nurses. This article provides an overview of the science and presents common examples of PGx as it relates to drug and/or drug dose selection.
View Article and Find Full Text PDFProselytizing or spiritual care?
J Christ Nurs
October 2006
Cedarville University in Cedarville, Ohio, USA.